Christopher Ma

No ORCID on file · 2 papers in corpus
observational 2021
Gastroenterology ·doi:10.1053/j.gastro.2020.09.041

BACKGROUND & AIMS: Functional bowel disorders (FBDs) are the most common gastrointestinal problems managed by physicians. We aimed to assess the burden of chronic symptomatic FBDs on ambulatory care delivery in the United States and evaluat…

observational 2018
Therapeutic advances in gastroenterology ·doi:10.1177/1756284818783614

BACKGROUND: Vedolizumab (VDZ) is a gut-specific α4-β7 integrin antagonist that has demonstrated efficacy in Crohn's disease (CD) and ulcerative colitis (UC). The safety of VDZ in the perioperative period remains unclear. The aim of this stu…